haemaccel
Sign in to saveAlso known as polygeline
Haemaccel (a registered trademark) is a type of intravenous colloid used in the prevention or treatment of shock associated with reduction in effective circulating blood volume due to hemorrhage, loss of plasma (burns, peritonitis, pancreatitis, crush injuries), or loss of water and electrolytes from persistent vomiting and diarrhea. Haemaccel contains degraded gelatin.
Research
471 papers- Haemaccel.The Medical journal of Australia · 1981
- [Haemaccel (Hoechst)].Lakartidningen · 1968
- [Immunological studies with Haemaccel].Deutsche medizinische Wochenschrift (1946) · 1962
- Cardiac arrest following Haemaccel.Anaesthesia and intensive care · 1994
- Vancomycin interaction with Haemaccel.Journal of cardiothoracic and vascular anesthesia · 2003
via PubMed
Clinical Trials
2 registered- PHASE4COMPLETEDThe Aim of This Study is to Investigate the Persistence of Antibody Response in Adults up to 15 Years After One Booster Dose of GlaxoSmithKline (GSK) Biologicals' Encepur Adults VaccineGlaxoSmithKline · NCT03294135
- UNKNOWNEchocardiographic Assessment of Intrapulmonary Vasodilatation: Agitated Saline Versus PolygelineMedical University of Vienna · NCT00343122
~1 min read
Article
1 sectionsContents
- References
Haemaccel (a registered trademark) is a type of intravenous colloid used in the prevention or treatment of shock associated with reduction in effective circulating blood volume due to hemorrhage, loss of plasma (burns, peritonitis, pancreatitis, crush injuries), or loss of water and electrolytes from persistent vomiting and diarrhea. Haemaccel contains degraded gelatin.
It is used as an alternative to human albumin solution (HAS) and starch in supportive treatment of ascites following the procedure of paracentesis.